Division 2.3.1 Supporting key Community strategies on addictive substances
United Kingdom
- (1)
In support of further developing the work on tobacco, projects proposals should focus on:
-
Mapping, assessment evaluation and dissemination of recent developments and best practice in tobacco control in the Member States, targeting in particular young people and women; communication strategies for prevention and cessation and addressing socio-economic aspects;
-
Develop and network prevention and cessation activities, focusing on innovative approaches to denormalisation and on reducing exposure to tobacco smoke;
-
Other EU and internal activities to implement requirements derived from the Framework Convention on Tobacco Controlf1, such as work on tobacco ingredients, surveillance or illicit trade in tobacco products.
-
- (2)
On alcohol, activities will be linked to the overall strategic approach to reducing alcohol-related harm. The priority will be to support networking that brings together a coordinated and comprehensive range of activities in fields such as research, information, consumer protection, transport, commercial communications and other internal market issues, drawing on country-based experiences. This could involve inter alia:
-
Developing an inventory and monitoring of country-based experiences;
-
Economic and health impact assessments of different policy options;
-
Capacity building for effective programme and policy implementation.
-
- (3)
On drugs, in line with the EU Drugs Strategyf2 and Action Planf3 and the Council Recommendation on Drugsf4, priority will be given to proposals on:
-
Harm reduction responses to emerging trends related to psychoactive substances with a focus on ecstasy, crack/cocaine and cannabis use;
-
Development or improvement and implementation of joint prevention programmes in public services, education and relevant NGOs focusing on socially disadvantaged groups;
-
An inventory of good practice on drug treatment and its effects, covering also reintegration, to follow-up actions set out in the Action Plan.
-
Annotations
Footnotes
- f1
-
Council Decision No 2004/513/EC of 2 June 2004 concerning the conclusion of the WHO Framework Convention on Tobacco Control (OJ L 213, 15.6.2004, p. 8).
- f2
-
EU Drugs Strategy [2005-2012]. See http://europa.eu.int/comm/health/ph_determinants/life_style/keydo_drug_en.htm
- f3
-
EU Action Plan on Drugs [2005-2008]. See http://europa.eu.int/comm/health/ph_determinants/life_style/keydo_drug_en.htm
- f4
-
Council Recommendation of 18 June 2003 on the prevention and reduction of health-related harm associated with drug dependence (OJ L 165, 3.7.2003, p. 31).
Notes on Division 2
Footnotes
- f1
-
Decision No 1513/2002/EC of the European Parliament and of the Council of 27 June 2002 (OJ L 232, 29.8.2002, p. 1).
- f2
-
Refer also to FP6 Scientific Support to Policies, 5th Call, SSP-5A Areas 2.1 & 2.2.
See: http://fp6.cordis.lu/index.cfm?fuseaction=UserSite.FP6ActivityCallsPage&ID_ACTIVITY=500
- f3
-
Council Decision 2002/834/EC of 30 September 2002 adopting a specific programme for research, technological development and demonstration ‘Integrating and Strengthening the European Research Area’ (2002-2006) (OJ L 294, 29.10.2002, p. 1).
- f4
-
The CORDIS web site links to the FP6 Priority 1 is http://www.cordis.lu/lifescihealth/ssp.htm